FDA Grants Orphan Drug Designation for Mithridion, Inc.'s MCD-386CR to Treat Progressive Supranuclear Palsy
5/9/2011 8:57:22 AM
More...
|
Mithridion, Inc. Announces $1.25 Million in New Funding and Outlines Strategy for Central Nervous System Drug Development
1/11/2011 6:59:57 AM
More...
|
Mithridion, Inc. Announces Progress With Drugs for Alzheimer's Disease and Schizophrenia
11/12/2009 8:15:52 AM
More...
|
Mithridion, Inc. Announces Phase I Study Results in Alzheimer’s Disease
4/8/2009 9:49:50 AM
More...
|
Mithridion, Inc. Announces Phase I Study Results in Alzheimer’s Disease
4/7/2009 10:00:57 AM
More...
|
New Venture Funding for Alzheimer's Disease Drug Developer, Mithridion, Inc.
1/12/2009 8:41:32 AM
More...
|
Startup Biotech Mithridion, Inc. Lands Funding
2/2/2006 2:54:06 PM
More...
|